| EDUCATIONAL FORUM |
|
| Year : 2019 | Volume
: 51
| Issue : 4 | Page : 236-242 |
“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
Jai Prakash, Kalpana Joshi, Deepak Malik, Omkar Mishra, Akhilesh Sachan, Bharat Kumar, Shashi Bhushan, Vivekanandan Kalaiselvan, Gyanendra Nath Singh
National Coordination Centre, Pharmcovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India
Correspondence Address:
Dr. Jai Prakash
Sector 23, Raj Nagar, Ghaziabad - 201 002, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_595_18
BACKGROUND: To improve the public health and promote instant adverse drug reaction (ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) mobile app was identified by the National Coordination CentrePvPI (NCCPvPI) to serve the Pan India ADR reporting. The objective of this study was to develop an indigenous Googlebased Android mobile application known as “ADR PvPI” and to analyze the ADRrelated data reported through this mobile application on pilot basis.
MATERIALS AND METHODS: The ADR PvPI mobile application was indigenously developed by NCCPvPI officials within 6 months. The study of spontaneous ADR reporting was carried out between September 2017 and September 2018. This article provides an overview of the salient features of ADR PvPI mobile application, guides on how to fillin ADRs, reporting trends of ADR, types of ADR as per System Organ Class and pharmacological classes of drugs.
RESULTS: Till date, >5500 users have downloaded the app with an average rating of 4.26. In that tenure, 262 reports have been received through ADR PvPI mobile app. During the year 2017, 3.55% of reports were received through ADR PvPI mobile app and the percentage of reports received by 2018 was 96.45%.
CONCLUSION: The frequency of ADR reporting has significantly increased over the past 1 year and should be promoted further through awareness and training programs.
[FULL TEXT] [PDF]*
|
